Insufficient scRNA-seq data for expression of A3GALT2 at single-cell level.
Insufficient scRNA-seq data for expression of A3GALT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 93% | 7.39 | 606 / 653 | 1% | 0.01 | 4 / 605 |
spleen | 90% | 10.00 | 216 / 241 | 0% | 0 | 0 / 0 |
lung | 82% | 7.06 | 474 / 578 | 3% | 0.05 | 32 / 1155 |
uterus | 75% | 4.55 | 128 / 170 | 8% | 0.12 | 37 / 459 |
ovary | 74% | 3.76 | 134 / 180 | 8% | 0.15 | 34 / 430 |
breast | 80% | 6.19 | 366 / 459 | 2% | 0.06 | 24 / 1118 |
blood vessel | 82% | 7.10 | 1090 / 1335 | 0% | 0 | 0 / 0 |
prostate | 80% | 5.65 | 196 / 245 | 0% | 0.00 | 1 / 502 |
adipose | 80% | 6.18 | 962 / 1204 | 0% | 0 | 0 / 0 |
bladder | 76% | 4.52 | 16 / 21 | 0% | 0.01 | 2 / 504 |
brain | 63% | 4.30 | 1670 / 2642 | 11% | 0.20 | 79 / 705 |
kidney | 71% | 5.38 | 63 / 89 | 4% | 0.05 | 32 / 901 |
peripheral blood | 74% | 17.42 | 683 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 71% | 4.10 | 184 / 258 | 0% | 0.02 | 1 / 230 |
intestine | 67% | 3.72 | 651 / 966 | 1% | 0.01 | 3 / 527 |
esophagus | 62% | 3.40 | 902 / 1445 | 4% | 0.07 | 8 / 183 |
stomach | 61% | 3.43 | 220 / 359 | 3% | 0.05 | 8 / 286 |
muscle | 61% | 3.55 | 486 / 803 | 0% | 0 | 0 / 0 |
skin | 57% | 2.62 | 1033 / 1809 | 2% | 0.04 | 11 / 472 |
liver | 54% | 2.26 | 121 / 226 | 0% | 0 | 0 / 406 |
pancreas | 49% | 1.90 | 161 / 328 | 0% | 0 | 0 / 178 |
heart | 49% | 2.11 | 421 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.32 | 9 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0030259 | Biological process | lipid glycosylation |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031982 | Cellular component | vesicle |
GO_0047276 | Molecular function | N-acetyllactosaminide 3-alpha-galactosyltransferase activity |
GO_0016757 | Molecular function | glycosyltransferase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0001962 | Molecular function | alpha-1,3-galactosyltransferase activity |
Gene name | A3GALT2 |
Protein name | Alpha-1,3-galactosyltransferase 2 (EC 2.4.1.87) (Isoglobotriaosylceramide synthase) (iGb3 synthase) (iGb3S) |
Synonyms | A3GALT2P IGBS3S |
Description | FUNCTION: Synthesizes the galactose-alpha(1,3)-galactose group on the glycosphingolipid isoglobotrihexosylceramide or isogloboside 3 (iGb3) by catalyzing the transfer of galactose from UDP-Galactose to its acceptor molecule Gal-beta-1,4-Glc-ceramide. Can also catalyze the addition of galactose to iGb3 itself to form polygalactose structures. . |
Accessions | U3KPV4 ENST00000442999.3 |